Health
Researchers use genetics to identify potential drugs for early management of COVID-19 – News-Medical.net
A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages….
A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages.
The findings appeared online in the journal Nature Medicine in March 2021.
Based on their analyses, the researchers are calling for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2. The goal is to identify existing drugs, either FDA-approved or in clinical development for other conditions, that can be repurposed…
-
Noosa News22 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General22 hours agoa pivotal moment in Liberal power struggle
-
General20 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter
-
Business12 hours agoBell Potter names the best ASX shares to buy in October